Strategy for Implementation of 2018 FDA Bioanalytical Method Validation Guidance and Proactively Addressing the ICH M10 BMV Draft Guideline Internally and/or with Outsourcing Partners - Alturas Analytics, Inc.

Strategy for Implementation of 2018 FDA Bioanalytical Method Validation Guidance and Proactively Addressing the ICH M10 BMV Draft Guideline Internally and/or with Outsourcing Partners
Presented by Katherine Yahvah, PhD, during PBSS 2019

Please complete the form below in order to access our resource:

"*" indicates required fields

First Name*

Last Name*

Company*

Email*

Phone*

Interest*

Message

Unique ID

This field is hidden when viewing the form

UTM Term

This field is hidden when viewing the form

UTM Content

This field is hidden when viewing the form

UTM Campaign

This field is hidden when viewing the form

UTM Medium

This field is hidden when viewing the form

UTM Source

© 2026 Alturas Analytics. All rights reserved